Retacrit — Blue Cross Blue Shield of New Mexico
Allogenic blood transfusion in a surgery patient
Initial criteria
- Length of approval depends on indication and plan type as specified
Approval duration
3mo–12mo depending on indication and plan
Allogenic blood transfusion in a surgery patient
3mo–12mo depending on indication and plan